Insider Trading activities at Biomarin Pharmaceutical Inc (BMRN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.

Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.

1 2 3 4 5 6 7 8 9 10 11

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Biomarin Pharmaceutical Inc* (*BMRN*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	0	$0	11,732	$809,525	0	$0
2024	0	$0	255,921	$21,765,611	199,347	$12,744,795
2023	0	$0	291,124	$29,165,285	298,974	$20,261,651
2022	3,625	$314,468	311,275	$27,255,098	253,242	$11,640,873
2021	0	$0	191,799	$15,370,940	178,931	$4,916,104
2020	12,800	$1,005,145	360,561	$39,226,570	301,650	$13,887,132
2019	0	$0	186,014	$16,384,008	131,953	$2,232,548
2018	0	$0	443,177	$39,824,783	396,390	$13,170,758
2017	0	$0	308,037	$28,193,855	265,930	$7,893,265
2016	0	$0	1,279,525	$111,508,495	1,208,448	$28,339,513
2015	0	$0	411,289	$48,410,265	295,446	$6,663,831
2014	0	$0	340,526	$26,836,672	306,781	$7,721,726
2013	0	$0	742,342	$47,391,614	730,412	$15,099,577
2012	0	$0	1,247,954	$51,415,184	1,198,637	$17,833,395
2011	0	$0	332,106	$9,638,946	335,054	$4,369,131
2010	800	$16,062	564,962	$13,310,700	545,102	$7,510,310
2009	26,500	$306,434	74,572	$1,277,220	83,753	$455,350
2008	16,752	$218,171	1,172,420	$39,560,526	973,113	$8,505,589
2007	17,587	$107,335	576,356	$12,583,816	477,563	$3,277,058
2006	35,493	$362,571	184,500	$2,780,052	284,500	$1,766,260
2005	12,000	$103,551	81,142	$826,127	0	$0

Table 2. Monthly summary of insider trading at *Biomarin Pharmaceutical Inc* (*BMRN*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-05	0	$0	2,059	$123,650	0	$0
2025-03	0	$0	8,329	$593,973	0	$0
2025-02	0	$0	1,344	$91,902	0	$0
2024-11	0	$0	5,278	$350,321	0	$0
2024-08	0	$0	714	$64,260	0	$0
2024-06	0	$0	0	$0	11,647	$734,925
2024-05	0	$0	92,700	$7,261,489	87,700	$5,533,870
2024-04	0	$0	42,286	$3,850,740	40,000	$2,524,000
2024-03	0	$0	63,943	$5,532,001	10,000	$797,000
2024-02	0	$0	31,000	$2,761,100	30,000	$1,893,000
2024-01	0	$0	20,000	$1,945,700	20,000	$1,262,000
2023-12	0	$0	13,764	$1,311,709	0	$0
2023-08	0	$0	43,360	$3,901,025	0	$0
2023-05	0	$0	90,000	$8,552,490	153,500	$10,408,835
2023-04	0	$0	28,500	$2,782,165	28,500	$1,932,585
2023-03	0	$0	23,000	$2,107,800	23,000	$1,559,630
2023-02	0	$0	21,000	$2,306,550	22,474	$1,523,961
2023-01	0	$0	71,500	$8,203,546	71,500	$4,836,640
2022-12	0	$0	21,001	$2,231,346	18,400	$1,188,829
2022-11	0	$0	8,379	$785,663	3,500	$237,335
2022-10	3,625	$314,468	5,500	$489,385	0	$0
2022-08	0	$0	70,921	$6,805,044	51,026	$3,460,073
2022-07	0	$0	14,735	$1,322,481	0	$0
2022-05	0	$0	62,333	$5,113,735	65,647	$2,459,136

Table 3. Detailed insider trading at *Biomarin Pharmaceutical Inc* (*BMRN*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-05-20	Burkhart Erin (GVP, Chief Accounting Officer)	Sale	1,786	59.31	105,927
2025-05-02	Hubbard Cristin (EVP, Chief Commercial Officer)	Sale	273	64.92	17,723
2025-03-19	Burkhart Erin (GVP, Chief Accounting Officer)	Sale	1,295	71.52	92,618
2025-03-06	Guyer Charles Greg (EVP, Chief Technical Officer)	Sale	7,034	71.28	501,355
2025-02-24	Burkhart Erin (GVP, Chief Accounting Officer)	Sale	1,344	68.38	91,902
2024-11-12	Guyer Charles Greg (EVP, Chief Technical Officer)	Sale	5,278	66.37	350,321
2024-08-13	Burkhart Erin (GVP, Chief Accounting Officer)	Sale	714	90.00	64,260
2024-06-03	Heron Elaine J (Director)	Option Ex	5,047	63.10	318,465
2024-06-03	Meier Richard A (Director)	Option Ex	6,600	63.10	416,460
2024-05-30	Mueller Brian (EVP, Chief Financial Officer)	Sale	5,000	75.19	375,950
2024-05-30	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	5,000	63.10	315,500
2024-05-28	Davis George Eric (EVP, Chief Legal Officer)	Sale	40,850	74.87	3,058,521
2024-05-28	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	40,850	63.10	2,577,635
2024-05-10	Bienaime Jean Jacques (Director)	Sale	20,000	81.14	1,622,800
2024-05-10	Bienaime Jean Jacques (Director)	Option Ex	20,000	63.10	1,262,000
2024-05-09	Bienaime Jean Jacques (Director)	Sale	20,000	81.62	1,632,400
2024-05-09	Bienaime Jean Jacques (Director)	Option Ex	20,000	63.10	1,262,000
2024-05-02	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	5,000	82.91	414,550
2024-05-02	Davis George Eric (EVP, Chief Legal Officer)	Sale	1,850	85.01	157,268
2024-05-02	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	1,850	63.10	116,735
2024-04-12	Bienaime Jean Jacques (Director)	Sale	20,000	91.26	1,825,200
2024-04-12	Bienaime Jean Jacques (Director)	Option Ex	20,000	63.10	1,262,000
2024-04-11	Bienaime Jean Jacques (Director)	Sale	20,000	90.99	1,819,800
2024-04-11	Bienaime Jean Jacques (Director)	Option Ex	20,000	63.10	1,262,000
2024-04-10	Burkhart Erin (GVP, Chief Accounting Officer)	Sale	2,286	90.00	205,740
2024-03-28	Davis George Eric (EVP, Chief Legal Officer)	Sale	24,602	88.34	2,173,340
2024-03-18	Slamon Dennis (Director)	Option Ex	10,000	79.70	797,000
2024-03-05	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	4,000	87.07	348,280
2024-03-05	Fuchs Henry J (President, Worldwide R&D)	Sale	35,341	85.18	3,010,381
2024-02-27	Bienaime Jean Jacques (Director)	Sale	1,000	90.35	90,350
2024-02-09	Bienaime Jean Jacques (Director)	Sale	15,000	88.28	1,324,200
2024-02-09	Bienaime Jean Jacques (Director)	Option Ex	15,000	63.10	946,500
2024-02-08	Bienaime Jean Jacques (Director)	Sale	15,000	89.77	1,346,550
2024-02-08	Bienaime Jean Jacques (Director)	Option Ex	15,000	63.10	946,500
2024-01-10	Bienaime Jean Jacques (Director)	Sale	10,000	96.38	963,800
2024-01-10	Bienaime Jean Jacques (Director)	Option Ex	10,000	63.10	631,000
2024-01-09	Bienaime Jean Jacques (Director)	Sale	10,000	98.19	981,900
2024-01-09	Bienaime Jean Jacques (Director)	Option Ex	10,000	63.10	631,000
2023-12-13	Davis George Eric (EVP, Chief Legal Officer)	Sale	13,764	95.30	1,311,709
2023-08-16	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	5,000	90.00	450,000
2023-08-10	Fuchs Henry J (President, Worldwide R&D)	Sale	12,000	90.43	1,085,112
2023-08-09	Guyer Charles Greg (EVP, Chief Technical Officer)	Sale	5,360	93.30	500,109
2023-08-08	Davis George Eric (EVP, Chief Legal Officer)	Sale	11,000	89.42	983,664
2023-08-08	Bienaime Jean Jacques (Chief Executive Officer)	Sale	6,000	88.29	529,740
2023-08-07	Bienaime Jean Jacques (Chief Executive Officer)	Sale	4,000	88.10	352,400
2023-05-12	Heron Elaine J (Director)	Option Ex	8,500	67.81	576,385
2023-05-12	Meier Richard A (Director)	Option Ex	8,500	67.81	576,385
2023-05-12	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	46,500	67.81	3,153,165
2023-05-11	Bienaime Jean Jacques (Chief Executive Officer)	Sale	30,000	94.89	2,846,550
2023-05-11	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	30,000	67.81	2,034,300
2023-05-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	30,000	95.00	2,849,850
2023-05-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	30,000	67.81	2,034,300
2023-05-09	Bienaime Jean Jacques (Chief Executive Officer)	Sale	30,000	95.20	2,856,090
2023-05-09	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	30,000	67.81	2,034,300
2023-04-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	99.56	995,600
2023-04-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	67.81	678,100
2023-04-06	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	96.13	961,300
2023-04-06	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	67.81	678,100
2023-04-03	Lawlis V Bryan (Director)	Sale	8,500	97.09	825,265
2023-04-03	Lawlis V Bryan (Director)	Option Ex	8,500	67.81	576,385
2023-03-13	Bienaime Jean Jacques (Chief Executive Officer)	Sale	8,000	90.45	723,600
2023-03-13	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	8,000	67.81	542,480
2023-03-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	15,000	92.28	1,384,200
2023-03-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	15,000	67.81	1,017,150
2023-02-24	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	1,474	67.81	99,951
2023-02-13	Bienaime Jean Jacques (Chief Executive Officer)	Sale	6,000	109.15	654,900
2023-02-13	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	6,000	67.81	406,860
2023-02-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	15,000	110.11	1,651,650
2023-02-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	15,000	67.81	1,017,150
2023-01-25	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	49,000	115.90	5,679,296
2023-01-25	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Option Ex	49,000	67.81	3,322,690
2023-01-17	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	111.55	1,115,500
2023-01-17	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	67.81	678,100
2023-01-13	Mueller Brian (EVP, Chief Financial Officer)	Sale	2,500	114.50	286,250
2023-01-13	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	2,500	63.10	157,750
2023-01-13	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	112.25	1,122,500
2023-01-13	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	67.81	678,100
2022-12-13	Mueller Brian (EVP, Chief Financial Officer)	Sale	7,500	107.50	806,250
2022-12-13	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	7,500	63.10	473,250
2022-12-02	Mueller Brian (EVP, Chief Financial Officer)	Sale	7,001	104.50	731,604
2022-12-02	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	5,900	67.81	400,079
2022-12-02	Bienaime Jean Jacques (Chief Executive Officer)	Sale	1,500	104.00	155,992
2022-11-23	Mueller Brian (EVP, Chief Financial Officer)	Sale	5,379	98.03	527,303
2022-11-23	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	3,500	67.81	237,335
2022-11-02	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	3,000	86.12	258,360
2022-10-31	Alles Mark J	Buy	3,625	86.75	314,468
2022-10-31	Bienaime Jean Jacques (Chief Executive Officer)	Sale	1,500	86.55	129,825
2022-10-14	Bienaime Jean Jacques (Chief Executive Officer)	Sale	4,000	89.89	359,560
2022-08-15	Bienaime Jean Jacques (Chief Executive Officer)	Sale	3,000	95.21	285,630
2022-08-12	Bienaime Jean Jacques (Chief Executive Officer)	Sale	4,000	94.75	379,000
2022-08-11	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	3,000	95.62	286,860
2022-08-09	Davis George Eric (EVP, Chief Legal Officer)	Sale	51,216	96.14	4,923,650
2022-08-09	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	47,526	67.81	3,222,738
2022-08-08	Guyer Charles Greg (EVP, Chief Technical Officer)	Sale	6,205	96.56	599,154
2022-08-05	Mueller Brian (EVP, Chief Financial Officer)	Sale	3,500	94.50	330,750
2022-08-05	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	3,500	67.81	237,335
2022-07-08	Mueller Brian (EVP, Chief Financial Officer)	Sale	7,337	89.50	656,661
2022-07-08	Davis George Eric (EVP, Chief Legal Officer)	Sale	7,398	90.00	665,820
2022-05-26	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	1,308	78.94	103,253
2022-05-06	Bienaime Jean Jacques (Chief Executive Officer)	Sale	20,000	81.00	1,620,000
2022-05-06	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	20,000	37.46	749,200
2022-05-05	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	84.14	841,400
2022-05-05	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	37.46	374,600
2022-05-04	Mueller Brian (EVP, Chief Financial Officer)	Sale	11,800	84.50	997,100
2022-05-04	Mueller Brian (EVP, Chief Financial Officer)	Option Ex	11,800	37.46	442,028
2022-05-02	Davis George Eric (EVP, Chief Legal Officer)	Sale	15,347	80.38	1,233,591
2022-05-02	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	15,347	37.46	574,898
2022-05-02	Meier Richard A	Sale	3,878	82.10	318,391
2022-05-02	Meier Richard A	Option Ex	8,500	37.46	318,410
2022-04-29	Bienaime Jean Jacques (Chief Executive Officer)	Sale	5,000	81.95	409,750
2022-04-29	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	5,000	37.46	187,300
2022-04-28	Bienaime Jean Jacques (Chief Executive Officer)	Sale	20,000	83.79	1,675,800
2022-04-28	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	20,000	37.46	749,200
2022-04-25	Davis George Eric (EVP, Chief Legal Officer)	Option Ex	2,669	37.46	99,980
2022-04-18	Bienaime Jean Jacques (Chief Executive Officer)	Sale	20,000	81.91	1,638,200
2022-04-18	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	20,000	37.46	749,200
2022-04-14	Lawlis V Bryan	Sale	4,250	83.66	355,555
2022-04-14	Lawlis V Bryan	Option Ex	4,250	37.46	159,205
2022-04-14	Bienaime Jean Jacques (Chief Executive Officer)	Sale	10,000	83.66	836,600
2022-04-14	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	10,000	37.46	374,600
2022-04-13	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	1,180	82.47	97,314
2022-03-30	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	1,381	79.56	109,872
2022-03-29	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	1,618	79.43	128,517
2022-03-23	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	6,129	81.78	501,229
2022-03-22	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	2,073	81.00	167,913
2022-03-21	Davis George Eric (EVP, General Counsel)	Sale	6,129	81.29	498,226
2022-03-11	Bienaime Jean Jacques (Chief Executive Officer)	Sale	15,000	77.81	1,167,150
2022-03-11	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	15,000	37.46	561,900
2022-03-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	15,000	77.57	1,163,550
2022-03-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	15,000	37.46	561,900
2022-02-28	Slamon Dennis	Sale	6,396	78.35	501,126
2022-02-25	Heron Elaine J	Option Ex	8,500	37.46	318,410
2022-01-14	Lawlis V Bryan	Sale	4,250	87.61	372,342
2022-01-14	Lawlis V Bryan	Option Ex	4,250	37.46	159,205
2022-01-13	Bienaime Jean Jacques (Chief Executive Officer)	Sale	5,000	87.86	439,300
2022-01-13	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	5,000	37.46	187,300
2022-01-12	Bienaime Jean Jacques (Chief Executive Officer)	Sale	5,000	89.00	445,000
2022-01-12	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	5,000	37.46	187,300
2021-12-16	Bienaime Jean Jacques (Chief Executive Officer)	Sale	6,000	84.68	508,080
2021-12-16	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	6,000	37.46	224,760
2021-12-15	Bienaime Jean Jacques (Chief Executive Officer)	Sale	6,000	82.71	496,259
2021-12-15	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	6,000	37.46	224,760
2021-12-01	Bienaime Jean Jacques (Chief Executive Officer)	Sale	1,500	87.22	130,831
2021-10-26	Ajer Jeffrey Robert (EVP, Chief Commercial Officer)	Sale	2,739	73.60	201,590
2021-10-20	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	1,000	37.46	37,460
2021-08-02	Davis George Eric (EVP, General Counsel)	Sale	5,518	76.69	423,175
2021-06-21	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	1,000	37.46	37,460
2021-05-10	Bienaime Jean Jacques (Chief Executive Officer)	Sale	8,513	77.29	657,969
2021-05-10	Bienaime Jean Jacques (Chief Executive Officer)	Option Ex	8,513	26.49	225,509
2021-05-07	Mueller Brian (EVP, Chief Financial Officer)	Sale	6,709	79.50	533,365

1 2 3 4 5 6 7 8 9 10 11

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month